Autoimmune hepatitis
Immune-mediated chronic hepatocellular inflammation (autoantibody-associated)
Overview
Chronic immune-mediated inflammation of the liver, typically in women (bimodal — young and peri/post-menopausal), associated with other autoimmune disease. Presents acutely (hepatitic) or with established chronic liver disease; raised IgG and autoantibodies (ANA, anti-smooth-muscle [type 1]; anti-LKM1 [type 2]). Responds to immunosuppression (steroids + azathioprine) — important because it's treatable.
Recognise
- Fatigue, jaundice, RUQ discomfort, amenorrhoea; or asymptomatic deranged LFTs; or acute hepatitis/acute liver failure
- Often other autoimmune disease (thyroid, coeliac, type 1 diabetes); women
- Raised IgG, positive ANA/anti-smooth-muscle (type 1) or anti-LKM1 (type 2); hepatitic LFTs
Red flags
- Acute liver failure presentation (coagulopathy/encephalopathy) → urgent specialist
- Progression to cirrhosis if untreated
Differentials & how to tell them apart
Investigations
Autoantibodies (ANA, anti-smooth-muscle, anti-LKM1), raised IgG; hepatitic LFTs; LIVER BIOPSY (interface hepatitis, plasma cells); exclude viral/other causes.
Management
Immunosuppression — prednisolone (induce) + azathioprine (maintain)
- 1Confirm with autoantibodies/IgG and biopsy after excluding other causes. Induce remission with corticosteroids; add azathioprine for maintenance/steroid-sparing.Gate: It is a TREATABLE cause of deranged LFTs/cirrhosis — recognise the autoantibody/raised-IgG pattern in a woman with another autoimmune disease and treat with immunosuppression rather than missing it
- 2Long-term azathioprine; monitor LFTs/IgG; transplant for end-stage disease; manage overlap syndromes.
Key points
Woman + other autoimmune disease + hepatitic LFTs + ANA/anti-smooth-muscle + raised IgG = autoimmune hepatitis → steroids + azathioprine. Treatable — don't miss it.
Monitor & prognosis
LFTs/IgG; cirrhosis surveillance.
Good with treatment; cirrhosis if missed.
Source: BSG; EASL